Georgia Cancer Info A Service of GeorgiaCORE     Admin Login  |  My Saved Results  |  Contact Us
Search the Website
Find Clinical Trials  |  About Clinical Trials  |  Glossary  |  Fast Facts  |  Eligibility  |  Phases  |  Sponsors  |  Types of Clinical Trials
HomeClinical TrialsHexvix Cystoscopy for Detection of Bladder Cancer

Tell Us What You Think

In an effort to give you the best possible service, we would be grateful if you could take a few minutes of your time to answer a few questions.

 

Hexvix Cystoscopy for Detection of Bladder Cancer

Status: Active printPrint Results Email Results Save Results
Cancer Type: NCT ID: NCT00209157
Trial Phases: Phase III Protocol IDs: PC B305/04 (primary)
Eligibility: 18 and over, Male and Female Study Type: Diagnostic
Study Sponsor: Winship Cancer Institute of Emory University
NCI Full Details: http://clinicaltrials.gov/show/NCT00209157

Summary

Hexvix is a photo-dynamic agent which fluoresces and is taken by tumor tissue in the bladder. When viewed under blue light cystoscopy, tumor areas appear red.

Georgia Cancer Info
Copyright 2014, Georgia Center for Oncology Research and Education, Inc. All Rights Reserved.
Website Designed by Peachtree Solutions

Privacy and Site Use Policies